Alputon Inc.

A fully integrated chemical technology platform, acquired from ArQule Inc., MA, USA , is now operational at the state of the art facility of Alputon Inc. at Pharma Valley of Zhangjiang Hi-tech Park in Shanghai. Its unparalleled capacities and capabilities in parallel synthesis and high throughput LC-MS purification of small to medium size of compound libraries distinguish greatly Alputon from other service providers. High quality of the final compounds and exceptional speed of delivery of services are great values that we promise to deliver to our clients.

The senior leadership team has had more than 10 year managerial experience in the R&D service sector in USA. Our leaders have had proven track records of managing collaborations with global pharmaceutical and biotech companies. Our key competences are well balanced in the following disciplines:
• Parallel synthesis and purification
• Organic synthesis and process chemistry
• Medicinal chemistry
• Analytical chemistry
• Computational chemistry and drug design
• Informatics and automation
• Engineering
• Preclinical development

Alputon Inc.'s vision is to enable our clients to shorten the time between initiating a drug discovery program and filing an NDA, to reduce overall cost of pharmaceutical R&D, and ultimately to facilitate the commercialization of innovative drugs for unmet medical needs. To mitigate the risk of our clients' R&D investment and to maximize their chance of success in bringing in a drug to market, we are fully committed to delivering reliable services (such as chemistry and ADMET) to our clients, and constantly working on innovative solutions to our clients' problems. Clients' needs, our talents, mentality, technology, process and culture are key ingredients for Alputon's innovations.